GSK-2193874

N/A

Report date: 2025/03/19 18:17:35
NME

Base Information

Drug NameGSK-2193874
Drug Alias NameGSK-2193874
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTransient receptor potential cation channel subfamily V member 4 inhibitors
TargetsTransient receptor potential cation channel subfamily V member 4
Therapy Area/IndicationsHeart FailurePulmonary Edema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsHeart FailurePulmonary Edema

Other Information

ATC CodeN/A
Related LinksN/A